| http://www.w3.org/ns/prov#value | - Although most of the recommendations are exactly or mostly the same as in the 2007 version or in published updates, the new guidelines reflect the endorsement of designated stroke centers and the vast experience with intravenous tissue plasminogen activator (tPA) since its approval by the FDA in 1996.
|
